GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.

Optum Rx has eliminated reauthorization for almost 70 drugs for chronic diseases, about 10% of its overall pharmacy prior ...

GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.

ByInvesting.com • Mar 13, 2018 UnitedHealth taps ex-GSK chief Witty to head Optum unit; shares up 1% UnitedHealth Group (UNH +1.4%) appoints ex-GlaxoSmithKline (GSK -1.5%) CEO Andrew Witty as ...

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

A massive pension plan in California alleges UnitedHealth Group has engaged in a wrongful profit-making scheme through its ...

UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ... UnitedHealth's Medicare billing practices in a letter to CEO Andrew Witty, amid reports suggesting the ...

Optum Rx announced Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. The pharmacy benefit management arm of UnitedHealth Group said it will work with ...

Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager announced Thursday. The company said it will shift to a cost-based model ...